Merck & Co. Files 8-K on Financials

Ticker: MRK · Form: 8-K · Filed: 2025-10-30T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, debt-filing, sec-filing

Related Tickers: MRK

TL;DR

Merck dropped an 8-K detailing its financial condition and various notes due in the coming years.

AI Summary

Merck & Co., Inc. filed an 8-K on October 30, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, detailing various notes with interest rates and maturity dates, such as Sec1.875NotesDue2026 and Sec3.750NotesDue2054.

Why It Matters

This 8-K filing provides investors with an update on Merck's financial performance and condition, including details on its outstanding debt instruments.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Merck & Co., Inc.?

The primary purpose is to report on Merck's Results of Operations and Financial Condition, as well as to file Financial Statements and Exhibits.

What is Merck & Co., Inc.'s Central Index Key (CIK)?

Merck & Co., Inc.'s Central Index Key is 0000310158.

What is Merck's Standard Industrial Classification (SIC) code?

Merck's SIC code is 2834, which corresponds to Pharmaceutical Preparations.

What are some of the debt instruments mentioned in the filing?

The filing mentions several debt instruments including Sec1.875NotesDue2026, Sec3.250NotesDue2032, Sec2.500NotesDue2034, Sec1.375NotesDue2036, Sec3.500NotesDue2037, Sec3.700NotesDue2044, and Sec3.750NotesDue2054.

What is Merck's business address?

Merck's business address is 126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065.

From the Filing

0001104659-25-103974.txt : 20251030 0001104659-25-103974.hdr.sgml : 20251030 20251030064038 ACCESSION NUMBER: 0001104659-25-103974 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20251030 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251030 DATE AS OF CHANGE: 20251030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 251432083 BUSINESS ADDRESS: STREET 1: 126 EAST LINCOLN AVENUE STREET 2: P.O. BOX 2000 CITY: RAHWAY STATE: NJ ZIP: 07065 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 126 EAST LINCOLN AVENUE STREET 2: P.O. BOX 2000 CITY: RAHWAY STATE: NJ ZIP: 07065 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 8-K 1 tm2529620d1_8k.htm FORM 8-K false 0000310158 0000310158 2025-10-30 2025-10-30 0000310158 us-gaap:CommonStockMember 2025-10-30 2025-10-30 0000310158 mrk:Sec1.875NotesDue2026Member 2025-10-30 2025-10-30 0000310158 mrk:Sec3.250NotesDue2032Member 2025-10-30 2025-10-30 0000310158 mrk:Sec2.500NotesDue2034Member 2025-10-30 2025-10-30 0000310158 mrk:Sec1.375NotesDue2036Member 2025-10-30 2025-10-30 0000310158 mrk:Sec3.500NotesDue2037Member 2025-10-30 2025-10-30 0000310158 mrk:Sec3.700NotesDue2044Member 2025-10-30 2025-10-30 0000310158 mrk:Sec3.750NotesDue2054Member 2025-10-30 2025-10-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934   Date of Report (Date of earliest event reported) October 30, 2025 ( October 30, 2025 )   Merck & Co., Inc. (Exact name of registrant as specified in its charter)   New Jersey (State or other jurisdiction of incorporation)   1-6571 (Commission File Number)   22-1918501 (I.R.S. Employer Identification No.)   126 East Lincoln Avenue , Rahway , NJ (Address of principal executive offices)   07065 (Zip Code)   Registrant’s telephone number, including area code ( 908 ) 740-4000   Not Applicable (Former name or former address, if changed since last report.)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock ($0.50 par value)   MRK   New York Stock Exchange 1.875% Notes due 2026   MRK/26   New York Stock Exchange 3.250% Notes due 2032   MRK/32   New York Stock Exchange 2.500% Notes due 2034   MRK/34   New York Stock Exchange 1.375% Notes due 2036   MRK 36A   New York Stock Exchange 3.500% Notes due 2037   MRK/37   New York Stock Exchange 3.700% Notes due 2044   MRK/44   New York Stock Exchange 3.750% Notes due 2054   MRK/54   New York Stock Exchange   Indicate by check mark whether the re

View on Read The Filing